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Mean  (± SD)
Acute Myocardial Infarction 4,852 1.9 4.1 (2.0)
Unstable Angina 2,467 0.0 5.2 (2.0)
Thromboembolic Disorder‡ 2,467 0.0 5.2 (2.0)
Dementia 4,363 3.6 3.9 (2.0)
Lung Disease* 11,121 3.6 3.7 (1.9)
Liver Disease 1,245 2.8 3.9 (2.0)
Dyslipidemia 16,690 2.7 3.7 (1.8)
Hypertension 21,121 4.8 3.5 (1.8)
Diabetes Mellitus 7,741 1.5 4.2 (1.8)
Aortic Valvular Disease 7,472 3.0 3.8 (1.9)
Peripheral Arterial Disease 3,156 2.1 4.2 (2.0)
Depression 6,605 2.6 4.1 (2.0)
Cancer 2,536 3.6 3.8 (1.9)
Visual Impairments 15,089 3.2 3.7 (1.8)
Hearing Impairment 6,789 3.3 3.8 (1.9)
Stroke** 7,469 1.9 4.2 (1.9)
Arrhythmia*** 8,857 4.7 3.7 (1.9)
This project was supported by Award Number U19HL091179 from the National Heart, 
Lung, And Blood Institute.
RESULTS
DISCUSSION & CONCLUSIONS
•Cluster analysis is an innovative 
approach to examining the co-occurrence 
of diseases and allows for identification of 
broad patterns of multi-morbidity beyond 
the pairings of diseases or disease 
counts. 
• Patients with HF have a high rate of 
multi-morbidity, with an average of 4 co-
occurring conditions. Intuitive and 
unintuitive patterns of clustering were 
identified.
• Randomized clinical trials in HF will 
need to include more diverse patient 
populations in order to adapt to the 
increasingly complex patient population.
• A cluster analysis approach to 
characterizing patterns of comorbidity 
may help indentify important patient 
subgroups.
Burden of Comorbidity
There was a high degree of comorbidity and multi-
morbidity among patients with HF. (Table 1) 
Hypertension and arrhythmias were the 
comorbidities of HF that occurred most often in the 
absence of other chronic conditions (4.8% and 
4.7%, respectively). The average number of 
comorbid conditions varied from 3.5 to 5.2. 
Patients with HF and unstable angina or other 
thromboembolic disorders had the highest multi-
morbidity (mean = 5.2 conditions), whereas those 
with HF and hypertension had the lowest (mean = 
3.5).
Clustering of Comorbiditites
A five-cluster structure was derived. (Figure 1)
Cluster 1:  Dyslipidemia, Hypertension, Diabetes 
Mellitus, Visual Impairment
Cluster 2: Acute Myocardial Infarction, Unstable 
Angina, Thromboembolic Disorder, Dementia 
Cluster 3: Aortic Valvular Disease, Cancer, 
Hearing Impairment, Arrthythmia 
Cluster 4: Peripheral Arterial Disease, Stroke 
Cluster 5: Lung Disease, Liver Disease, 
Depression
Table 1. Patients with Heart Failure Affected by Each Chronic 
Disease and Degree of Multi-Morbidity (N = 37,054)
‡ Based on inpatient primary discharge diagnoses: 440.0, 444.1, 444.21, 444.22, 444.81, 444.89, 
557.0, 557.1, 557.9 ; * Based on inpatient primary discharge diagnosis or outpatient diagnosis 
490-496; 518 * Includes ischemic stroke, transient ischemic attack, and cerebrovascular disease;  
*** Includes atrial fibrillation, atrial flutter, ventricular fibrillation, ventricular tachycardia
BACKGROUND
Heart failure (HF) carries a high burden of 
comorbidity with approximately one half of 
patients with HF having at least one additional  
comorbid condition present. Rates of comorbidity 
in patients with HF have steadily increased over 
the past 2 decades.
METHODS
PRESERVE Cohort
Data are from the CVRN PRESERVE cohort 
which is a multicenter cohort of 37,054 patients 
[mean age = 74 years (SD = 12.4 yrs); 46% 
female] with HF diagnosed between 2005 and 
2008 currently being conducted at 4 CVRN sites: 
KPNC, KPCO, KPNW, and FCHP. The primary 
data source for the PRESERVE cohort was the 
HMO Research Network Virtual Data 
Warehouse.
Identification of Coexisting Diseases
Coexisiting illnesses at the time of HF diagnosis 
were based on diagnoses and procedures 
mapped to relevant International Classification of 
Diseases, Ninth Edition (ICD-9) codes. For the 
purposes of characterizing clusters of 
comorbidities, we focused on coexisting 
conditions with a prevalence rate of ≥3%.
OBJECTIVE
STATISTICAL  ANALYSIS
To examine patterns of comorbidity among  older 
patients with HF in the Cardiovascular Research 
Network PRESERVE cohort.
We used the Agglomerative Clustering technique 
to characterize patterns of comorbidity.  Over 
multiple iterations, each condition is clustered 
with the condition with which it has the highest 
squared correlation. This process is repeated to 
determine whether assigning a condition to a 
different cluster increases the amount of 
explained variance [ranging from 1.0 (all 
variance explained) to 0.0 (no variance 
explained)].  The conditions in each cluster are 
as correlated as possible among themselves and 
as uncorrelated as possible with conditions in 
other clusters.
The dendogram (Figure 1) is a graphical display 
of cluster results. 
Figure 1. Dendogram Resulting from Cluster Analysis of the Distribution and 
Aggregation of Chronic Disease in Patients with HF. 
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